loading

Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten

pulisher
Jul 06, 2026

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers - TradingView

Jul 06, 2026
pulisher
Jul 06, 2026

Amneal Sues Alembic to Block Copies of Crexont Parkinson’s Drug - Bloomberg Law News

Jul 06, 2026
pulisher
Jul 06, 2026

Amneal Pharmaceuticals updates investors on its generics and specialty pipeline. The company focuses - AD HOC NEWS

Jul 06, 2026
pulisher
Jul 05, 2026

$2M from Amneal targets Parkinson's drug costs for patients - Stock Titan

Jul 05, 2026
pulisher
Jul 04, 2026

Amneal Pharmaceuticals (AMRX) Gets EU Backing For Hopledo, Is It Fully Priced? - Sahm

Jul 04, 2026
pulisher
Jul 01, 2026

Price to sales forward of Amneal Pharmaceuticals, Inc. – NASDAQ:AMRX - TradingView

Jul 01, 2026
pulisher
Jul 01, 2026

Amneal Pharmaceuticals : New U.S. Sterile Manufacturing Facility Selected for FDA PreCheck Pilot Program - marketscreener.com

Jul 01, 2026
pulisher
Jul 01, 2026

Price to book forward of Amneal Pharmaceuticals, Inc. – NASDAQ:AMRX - TradingView

Jul 01, 2026
pulisher
Jun 30, 2026

Price to earnings forward of Amneal Pharmaceuticals, Inc. – NASDAQ:AMRX - TradingView

Jun 30, 2026
pulisher
Jun 29, 2026

Lilly, Regeneron selected for US program to review new manufacturing plants faster - Reuters

Jun 29, 2026
pulisher
Jun 29, 2026

Amneal to Buy Kashiv for $375M Cash + 28.9M Shares (NASDAQ: AMRX) - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

EMA Recommends Approval of Hopledo for Parkinson's Disease - Intellectia AI

Jun 29, 2026
pulisher
Jun 29, 2026

Zambon and Amneal Receive Positive CHMP Opinion for Hopledo in Parkinson’s Disease in Europe - Quiver Quantitative

Jun 29, 2026
pulisher
Jun 29, 2026

EU regulator backs Amneal’s Parkinson’s drug after Phase 3 data - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

Does Amneal (AMRX) Joining Three Russell 2000 Defensive Indexes Recast Its Risk Profile? - simplywall.st

Jun 29, 2026
pulisher
Jun 28, 2026

Amneal Pharmaceuticals, Inc.(NasdaqGS:AMRX) added to Russell 2000 Value-Defensive Index - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Amneal Pharmaceuticals, Inc.(NasdaqGS:AMRX) added to Russell 2000 Growth-Defensive Index - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Amneal Pharmaceuticals, Inc.(NasdaqGS: AMRX) added to Russell 2000 Defensive Index - marketscreener.com

Jun 28, 2026
pulisher
Jun 27, 2026

Form DEF 14A Amneal Pharmaceuticals Inc Class A For: 26 June - Investing.com UK

Jun 27, 2026
pulisher
Jun 27, 2026

2DT Forecast — Price Target — Prediction for 2027 - TradingView

Jun 27, 2026
pulisher
Jun 25, 2026

Amneal Pharmaceuticals, Inc. Class A Actuals & Estimates (NASDAQ:AMRX) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

AMRX Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Amneal Pharmaceuticals (AMRX) Short Interest & Short Float | Updated Jun 2026 - MarketBeat

Jun 25, 2026
pulisher
Jun 23, 2026

Amneal Pharmaceuticals advances after securing FDA clearance for cancer treatment (AMRX) - MSN

Jun 23, 2026
pulisher
Jun 23, 2026

Amneal Pharmaceuticals stock hits 52-week high at 16.62 USD - Investing.com

Jun 23, 2026
pulisher
Jun 23, 2026

Amneal Pharmaceuticals stock hits 52-week high at 16.62 USD By Investing.com - Investing.com South Africa

Jun 23, 2026
pulisher
Jun 22, 2026

Rytvela from Amneal Pharmaceuticals Inc.biosimilar for chronic uveitis care - AD HOC NEWS

Jun 22, 2026
pulisher
Jun 22, 2026

Amgen Inc. v. Amneal Pharm. LLC United States Court of Appeals of the Federal Circuit, 2020 945 F.3d 1368, 2020 - Sage Journals

Jun 22, 2026
pulisher
Jun 21, 2026

Amneal Pharmaceuticals (AMRX) Stock Could Be 6% Below Fair Value After Its Sharp Rally - Sahm

Jun 21, 2026
pulisher
Jun 18, 2026

Amneal (AMRX) agrees to buy Kashiv for $375M cash plus equity and milestones - Stock Titan

Jun 18, 2026
pulisher
Jun 17, 2026

Amneal Pharmaceuticals Inc (AMRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Amneal Pharmaceuticals Inc (AMRX) Institutional Confidence - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Amneal Pharmaceuticals Inc (AMRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Amneal Pharmaceuticals Inc (AMRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Amneal Pharmaceuticals Inc - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Amneal Pharmaceuticals, Inc. (AMRX) Latest Stock News & Headlines - Yahoo Finance

Jun 17, 2026
pulisher
Jun 17, 2026

US progesterone supplies tighten as menopause treatment demand grows - Reuters

Jun 17, 2026
pulisher
Jun 17, 2026

Amneal Pharmaceuticals Inc (AMRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 15, 2026

Top 3 Health Care Stocks That May Collapse This Quarter - Benzinga

Jun 15, 2026
pulisher
Jun 13, 2026

Amneal Pharmaceuticals (AMRX) Is Up 17.8% After CREXONT Phase 4 Gains And New Oncology Launch - Yahoo Finance

Jun 13, 2026
pulisher
Jun 11, 2026

Amneal Pharmaceuticals, Inc. (AMRX) hits fresh high: Is there still room to run? - MSN

Jun 11, 2026
pulisher
Jun 11, 2026

AMNEAL PHARMACEUTICALS, INC. (AMRX) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Jun 11, 2026
pulisher
Jun 11, 2026

Do options traders know something about Amneal stock we don't? - MSN

Jun 11, 2026
pulisher
Jun 11, 2026

Amneal Pharmaceuticals stock hits 52-week high at 15.44 USD By Investing.com - Investing.com Nigeria

Jun 11, 2026
pulisher
Jun 10, 2026

Is Amneal Pharmaceuticals Inc (AMRX) Overvalued After 4.4% Rally - GuruFocus

Jun 10, 2026
pulisher
Jun 10, 2026

Dispensary of Hope Launches "Hope Alliance" Campaign with Suppor - GuruFocus

Jun 10, 2026
pulisher
Jun 10, 2026

Amneal Pharmaceuticals stock hits 52-week high at 15.44 USD - Investing.com

Jun 10, 2026
pulisher
Jun 10, 2026

Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal Pharmaceuticals - marketscreener.com

Jun 10, 2026
$55.35
price up icon 0.15%
RDY RDY
$14.68
price up icon 2.19%
$24.71
price down icon 1.57%
$177.58
price up icon 2.00%
$17.00
price up icon 1.16%
$559.50
price up icon 2.20%
Kapitalisierung:     |  Volumen (24h):